Angelini Pharma SpA - Strategic SWOT Analysis Review
Description
Angelini Pharma SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Angelini Pharma Spa (Angelini Pharma) manufactures, markets, and commercializes pharmaceutical and healthcare products. The company operates in prescription and over-the-counter (OTC) pharmaceutical sectors with a focus on pain and inflammation disorders, traveler's diarrhea, infection control and infectious diseases, bacterial infections, mental health, and central nervous system diseases and disorders. Its products include benzydamine, trazodone, paracetamol, progesterone, glycerin, tetrahydrozoline, lactitol and prulifloxacin, among others. The company offers its products through brands such as Andolex, Trittico, Aulin, Tachipirina, Tantum, Lono, Vantal to Hospitals, Research Centers, Pharma Biotech and Contract Research Organizations. It operates manufacturing facilities in Italy, Spain, and the US. Angelini Pharma is headquartered in Rome, Italy.
Angelini Pharma SpA Key Recent Developments
Mar 19,2026: Angelini Pharma Joins Dialogue on Brain Health at Brain Awareness Week 2026
Feb 17,2026: Angelini Pharma Appoints Steve Guise As Chief Information And Digital Officer
Jan 21,2026: Angelini Pharma Appoints Sergio Marullo di Condojanni as CEO
Dec 05,2025: Headway Mental Health Index 5.0: a new European dialogue in Brussels
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Angelini Pharma Spa (Angelini Pharma) manufactures, markets, and commercializes pharmaceutical and healthcare products. The company operates in prescription and over-the-counter (OTC) pharmaceutical sectors with a focus on pain and inflammation disorders, traveler's diarrhea, infection control and infectious diseases, bacterial infections, mental health, and central nervous system diseases and disorders. Its products include benzydamine, trazodone, paracetamol, progesterone, glycerin, tetrahydrozoline, lactitol and prulifloxacin, among others. The company offers its products through brands such as Andolex, Trittico, Aulin, Tachipirina, Tantum, Lono, Vantal to Hospitals, Research Centers, Pharma Biotech and Contract Research Organizations. It operates manufacturing facilities in Italy, Spain, and the US. Angelini Pharma is headquartered in Rome, Italy.
Angelini Pharma SpA Key Recent Developments
Mar 19,2026: Angelini Pharma Joins Dialogue on Brain Health at Brain Awareness Week 2026
Feb 17,2026: Angelini Pharma Appoints Steve Guise As Chief Information And Digital Officer
Jan 21,2026: Angelini Pharma Appoints Sergio Marullo di Condojanni as CEO
Dec 05,2025: Headway Mental Health Index 5.0: a new European dialogue in Brussels
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
41 Pages
- Section 1 - About the Company
- Angelini Pharma SpA - Key Facts
- Angelini Pharma SpA - Key Employees
- Angelini Pharma SpA - Key Employee Biographies
- Angelini Pharma SpA - Major Products and Services
- Angelini Pharma SpA - History
- Angelini Pharma SpA - Company Statement
- Angelini Pharma SpA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Section 2 – Company Analysis
- Company Overview
- Angelini Pharma SpA - Business Description
- R&D Overview
- Angelini Pharma SpA - SWOT Analysis
- SWOT Analysis - Overview
- Angelini Pharma SpA - Strengths
- Angelini Pharma SpA - Weaknesses
- Angelini Pharma SpA - Opportunities
- Angelini Pharma SpA - Threats
- Angelini Pharma SpA - Key Competitors
- Section 3 – Company’s Lifesciences Financial Deals and Alliances
- Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Angelini Pharma SpA, Recent Deals Summary
- Section 4 – Company’s Recent Developments
- Mar 19, 2026: Angelini Pharma Joins Dialogue on Brain Health at Brain Awareness Week 2026
- Feb 17, 2026: Angelini Pharma Appoints Steve Guise As Chief Information And Digital Officer
- Jan 21, 2026: Angelini Pharma Appoints Sergio Marullo di Condojanni as CEO
- Dec 05, 2025: Headway Mental Health Index 5.0: a new European dialogue in Brussels
- Oct 07, 2025: ECNP 2025: Advancing Research In Brain Health
- Sep 22, 2025: Angelini Pharma Signs Exclusive Option Agreement With Sovargen
- Sep 11, 2025: Angelini Pharma Recognized as One of Italy's Best Employers for Women 2026
- Sep 05, 2025: Angelini Pharma at the 83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences
- Aug 27, 2025: Angelini Pharma at IEC 2025: real-world data and clinical dialogue to redefine seizure freedom
- Jun 19, 2025: Angelini Pharma at EAN Congress 2025: Rethinking Seizure Control, Together
- Section 5 – Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Angelini Pharma SpA, Key Facts
- Angelini Pharma SpA, Key Employees
- Angelini Pharma SpA, Key Employee Biographies
- Angelini Pharma SpA, Major Products and Services
- Angelini Pharma SpA, History
- Angelini Pharma SpA, Subsidiaries
- Angelini Pharma SpA, Joint Venture
- Angelini Pharma SpA, Key Competitors
- Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
- Angelini Pharma SpA, Recent Deals Summary
- List of Figures
- Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
- Angelini Pharma SpA, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
